Prostate Biopsy-related Infection

A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches

Matthew J. Roberts, Harrison Y. Bennett, Patrick N. Harris, Michael Holmes, Jeremy Grummet, Kurt G Naber, Florian M E Wagenlehner

Research output: Contribution to journalReview ArticleResearchpeer-review

26 Citations (Scopus)

Abstract

A systematic review to identify risk factors for prostate biopsy-related infection, preventative strategies, and optimal management of infectious complications was conducted. Significant risk factors for postbiopsy infection include urogenital infection, antibiotic use, international travel, hospital exposure, bacteriuria, previous transrectal biopsy, and resistance of fecal flora to antibiotic prophylaxis (especially fluoroquinolones). Patients at risk may benefit from an adjusted biopsy protocol comprising transrectal biopsy under targeted prophylaxis, and/or the use of rectal disinfection techniques or using a transperineal approach. Management of biopsy-related infection should be based on individual risk and local resistance profiles with input from multiple specialties.

Original languageEnglish
Pages (from-to)11-21
Number of pages11
JournalUrology
Volume104
DOIs
Publication statusPublished - 1 Jun 2017

Cite this

Roberts, Matthew J. ; Bennett, Harrison Y. ; Harris, Patrick N. ; Holmes, Michael ; Grummet, Jeremy ; Naber, Kurt G ; Wagenlehner, Florian M E. / Prostate Biopsy-related Infection : A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches. In: Urology. 2017 ; Vol. 104. pp. 11-21.
@article{5936bbd3f32e46448994411b9de89c53,
title = "Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches",
abstract = "A systematic review to identify risk factors for prostate biopsy-related infection, preventative strategies, and optimal management of infectious complications was conducted. Significant risk factors for postbiopsy infection include urogenital infection, antibiotic use, international travel, hospital exposure, bacteriuria, previous transrectal biopsy, and resistance of fecal flora to antibiotic prophylaxis (especially fluoroquinolones). Patients at risk may benefit from an adjusted biopsy protocol comprising transrectal biopsy under targeted prophylaxis, and/or the use of rectal disinfection techniques or using a transperineal approach. Management of biopsy-related infection should be based on individual risk and local resistance profiles with input from multiple specialties.",
author = "Roberts, {Matthew J.} and Bennett, {Harrison Y.} and Harris, {Patrick N.} and Michael Holmes and Jeremy Grummet and Naber, {Kurt G} and Wagenlehner, {Florian M E}",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.urology.2016.12.011",
language = "English",
volume = "104",
pages = "11--21",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier",

}

Prostate Biopsy-related Infection : A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches. / Roberts, Matthew J.; Bennett, Harrison Y.; Harris, Patrick N.; Holmes, Michael; Grummet, Jeremy; Naber, Kurt G; Wagenlehner, Florian M E.

In: Urology, Vol. 104, 01.06.2017, p. 11-21.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Prostate Biopsy-related Infection

T2 - A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches

AU - Roberts, Matthew J.

AU - Bennett, Harrison Y.

AU - Harris, Patrick N.

AU - Holmes, Michael

AU - Grummet, Jeremy

AU - Naber, Kurt G

AU - Wagenlehner, Florian M E

PY - 2017/6/1

Y1 - 2017/6/1

N2 - A systematic review to identify risk factors for prostate biopsy-related infection, preventative strategies, and optimal management of infectious complications was conducted. Significant risk factors for postbiopsy infection include urogenital infection, antibiotic use, international travel, hospital exposure, bacteriuria, previous transrectal biopsy, and resistance of fecal flora to antibiotic prophylaxis (especially fluoroquinolones). Patients at risk may benefit from an adjusted biopsy protocol comprising transrectal biopsy under targeted prophylaxis, and/or the use of rectal disinfection techniques or using a transperineal approach. Management of biopsy-related infection should be based on individual risk and local resistance profiles with input from multiple specialties.

AB - A systematic review to identify risk factors for prostate biopsy-related infection, preventative strategies, and optimal management of infectious complications was conducted. Significant risk factors for postbiopsy infection include urogenital infection, antibiotic use, international travel, hospital exposure, bacteriuria, previous transrectal biopsy, and resistance of fecal flora to antibiotic prophylaxis (especially fluoroquinolones). Patients at risk may benefit from an adjusted biopsy protocol comprising transrectal biopsy under targeted prophylaxis, and/or the use of rectal disinfection techniques or using a transperineal approach. Management of biopsy-related infection should be based on individual risk and local resistance profiles with input from multiple specialties.

UR - http://www.scopus.com/inward/record.url?scp=85008485873&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2016.12.011

DO - 10.1016/j.urology.2016.12.011

M3 - Review Article

VL - 104

SP - 11

EP - 21

JO - Urology

JF - Urology

SN - 0090-4295

ER -